Publications by authors named "Benjamin Vesin"

Claim this Profile
E
Enhanced hepatitis B virus-specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection.
Maxime Beretta, Benjamin Vesin, Yu Wei, Cyril Planchais, Pierre Rosenbaum

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy.
Anastasia Goloudina, Fabien Le Chevalier, Pierre Authié, Sylvain Ciret, Kirill Nemirov, Benjamin Vesin

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.
Benjamin Vesin, Ingrid Fert, Amandine Noirat, Pierre Authié, Sylvain Ciret

NPJ Vaccines· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Ingrid Fert, Laëtitia Douguet, Benjamin Vesin, Fanny Moncoq, Amandine Noirat

NPJ Vaccines· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.
Fabien Le Chevalier, Pierre Authié, Sébastien Chardenoux, Maryline Bourgine, Benjamin Vesin

Microbes Infect· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Laëtitia Douguet, Ingrid Fert, Jodie Lopez, Benjamin Vesin, Fabien Le Chevalier

EMBO Mol Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters.
Benjamin Vesin, Pierre Authié, Catherine Blanc, Ingrid Fert, Amandine Noirat

Vaccines (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Benjamin Vesin, Jodie Lopez, Amandine Noirat, Pierre Authié, Ingrid Fert

Mol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Cyril Planchais, Ignacio Fernández, Timothée Bruel, Guilherme Dias de Melo, Matthieu Prot, Benjamin Vesin

J Exp Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Min-Wen Ku, Pierre Authié, Maryline Bourgine, François Anna, Amandine Noirat, Benjamin Vesin

EMBO Mol Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Min-Wen Ku, Maryline Bourgine, Pierre Authié, Jodie Lopez, Kirill Nemirov, Benjamin Vesin

Cell Host Microbe· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.
Verena Hehle, Maxime Beretta, Maryline Bourgine, Malika Ait-Goughoulte, Cyril Planchais, Benjamin Vesin

J Exp Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis